Literature DB >> 14501965

Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.

H Alex Leather1, Kirsten Ver Eycken, Patrick Segers, Paul Herijgers, Eugène Vandermeersch, Patrick F Wouters.   

Abstract

OBJECTIVE: Levosimendan is a promising calcium sensitizer that potentially could be useful in settings of pulmonary vasoconstriction and right ventricular dysfunction. There is a shortage of information concerning its effects on right ventricular function and ventriculovascular coupling. The aim of the present study was to characterize the effects of levosimendan on right ventricular and pulmonary vascular function by means of pressure-volume and pulsatile flow analysis.
DESIGN: Prospective laboratory investigation.
SETTING: University hospital laboratory.
SUBJECTS: Eight landrace pigs (mean weight, 37 kg).
INTERVENTIONS: Following instrumentation with biventricular conductance catheters, pulmonary and right coronary artery flow probes, a high-fidelity pulmonary pressure catheter, and a right coronary venous catheter, hemodynamic measurements were performed in baseline conditions and during levosimendan infusion at three increasing plasma concentrations (mean values, 27.5, 67.6, and 142.5 ng/mL).
MEASUREMENTS AND MAIN RESULTS: Levosimendan increased heart rate and cardiac output, reduced systemic vascular resistance, and had a positive inotropic effect on the left ventricle and increased left ventricular mechanical efficiency. Moreover, levosimendan increased right ventricular contractility and hydraulic power. However, total pulmonary vascular resistance and characteristic impedance did not change throughout the protocol, and right ventricular mechanical efficiency decreased slightly at the highest concentration of levosimendan.
CONCLUSIONS: At clinical concentrations in the present model, levosimendan increases right ventricular contractility and performance without significantly influencing pulmonary vascular tone. Further studies are required in a model of pulmonary vasoconstriction to disclose possible pulmonary vasodilator effects of levosimendan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501965     DOI: 10.1097/01.CCM.0000084844.95073.C0

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles.

Authors:  Nóra Erdei; Zoltán Papp; Piero Pollesello; István Edes; Zsolt Bagi
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

2.  Acute effects of levosimendan in experimental models of right ventricular hypertrophy and failure.

Authors:  Mads D Vildbrad; Asger Andersen; Sarah Holmboe; Steffen Ringgaard; Jan M Nielsen; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 3.  [Role of Levosimendan in intensive care treatment of myocardial insufficiency].

Authors:  S Rehberg; C Ertmer; H Van Aken; M Lange; K Bröking; A Morelli; M Westphal
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

Review 4.  Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies.

Authors:  Mobusher Mahmud; Hunter C Champion
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

5.  Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.

Authors:  Mehmet Birhan Yilmaz; Can Yontar; Alim Erdem; Filiz Karadas; Kenan Yalta; Okan Onur Turgut; Ahmet Yilmaz; Izzet Tandogan
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

6.  Effects of Levosimendan on Right Ventricular Function in Patients with Acute Decompensated Heart Failure.

Authors:  Yan-Bo Wang; Guo-Zhen Hao; Yun-Fa Jiang; Xiang-Hua Fu; Wei-Ze Fan; Qing Miao; Qing Wang; Hong-Xiao Li; Xin-Shun Gu
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

7.  Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of KATP-Channels, cAMP and cGMP.

Authors:  Annette D Rieg; Rolf Rossaint; Eva Verjans; Nina A Maihöfer; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 8.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Authors:  Laura C Price; Stephen J Wort; Simon J Finney; Philip S Marino; Stephen J Brett
Journal:  Crit Care       Date:  2010-09-21       Impact factor: 9.097

Review 9.  Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.

Authors:  László Nagy; Piero Pollesello; Zoltán Papp
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

10.  Heart Transplantation in a 14-Year-Old Boy in the Presence of Severe Out-of-Proportion Pulmonary Hypertension due to Restrictive Left Heart Disease: A Case Report.

Authors:  Martin Schwienbacher; Ulrich Schweigmann; Nikolaus Neu; Elisabeth Schermer; Corinna Velik-Salchner; Ina Michel-Behnke; Erentraud Irnberger; Christina Maria Steger; Jörg Ingolf Stein; Ralf Geiger
Journal:  Case Rep Cardiol       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.